Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2025-12-25 @ 10:49 PM
Study NCT ID:
NCT04347967
Status:
UNKNOWN
Last Update Posted:
2023-12-04
First Post:
2020-04-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Mesenchymal Stem Cells for The Treatment of Acute Respiratory Distress Syndrome (ARDS)
Sponsor:
Meridigen Biotech Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-09
Completion Date Type:
ESTIMATED
First Submit Date:
2020-04-12
First Submit QC Date:
None
Study First Post Date:
2020-04-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-01
Last Update Post Date:
2023-12-04
Last Update Post Date Type:
ACTUAL